EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access

Absence of Detectable Anti‐ HDV Antibodies Among HBsAg ‐Positive Blood Donors, HIV ‐Infected Individuals and Patients With Chronic Hepatitis B in Sao Paulo, Brazil: Evaluation Using a Rapid Lateral Flow Assay

Anna S Nishiya iD, Cecilia S Alencar iD, Michele Soares Gomes Gouvea iD, Suzane K Ono, Nanci Alves Salles, Alfredo Mendrone iD, Gnimah Eva Gnouamozi, Shirin Nkongolo, Stephan Urban iD, Raymond F Schinazi iD, Leda Bassit

Journal of Viral Hepatitis · 2026-08 · 33 (8)

DOI: 10.1111/jvh.70217 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Journal of Viral Hepatitis, online erschienen am 28.07.2026. Verfasst von Anna S Nishiya und 10 weiteren Autor:innen. Beteiligte Einrichtung: Fundação Pró-Sangue/Hemocentro de São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Blood Donors, Hepatitis D, Hepatitis Antibodies, Hepatitis B, Chronic. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis Delta Virus (HDV) infection in HBV‐infected individuals is associated with severe clinical outcomes, and screening is recommended in HBsAg‐positive patients. We used a rapid lateral flow assay (LFA) to assess anti‐HDV antibodies in Brazil, where HDV is highly endemic in the North, while data from the Southeast, particularly São Paulo, remain limited. We conducted a retrospective cross‐sectional study to assess anti‐HDV antibodies among 46 HBsAg‐positive blood donors at Fundação Pró‐Sangue/Hemocentro de São Paulo, 381 patients with chronic hepatitis B from the Central Laboratory Division of HC‐FMUSP, and 189 individuals from the Hepatology Clinic of HC‐FMUSP (101 HIV‐infected and 88 chronically HBV‐infected). Anti‐HDV antibodies were detected using a validated LFA. Positive controls ( n = 24) included samples previously confirmed by ELISA and/or PCR, predominantly infected with HDV genotypes 3 and 8. Among 443,400 blood donations, 48 (0.01%) were positive for at least two HBV markers; of these, 46 were tested for HDV, and all were anti‐HDV negative. All 381 patients undergoing HBV viral load monitoring were anti‐HDV negative, as were all 189 patients receiving hepatology care, including those with HIV coinfection or advanced liver disease. The LFA correctly identified all control samples positive for both anti‐HDV antibodies and HDV RNA. The absence of detectable anti‐HDV among diverse at‐risk populations in São Paulo is consistent with the low endemicity of HDV infection in southeastern Brazil. These findings, together with the assay's high specificity in HDV RNA‐positive controls, support its potential utility as a screening tool for HDV infection in low‐prevalence settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood DonorsHepatitis DHepatitis AntibodiesHepatitis B, ChronicHepatitis Delta VirusHepatitis B Surface AntigensHIV InfectionsChromatography, AffinityHumansBrazilFemaleCross-Sectional StudiesMaleAdultRetrospective StudiesMiddle AgedYoung AdultRapid Diagnostic TestsSensitivity and Specificity

Stichwörter der Autor:innen

HBVHDVblood donorschronic hepatitis Brapid lateral flow assay

Substanzen

Hepatitis AntibodiesHepatitis B Surface Antigens

Autor:innen und Institutionen

  • Fundação Pró-Sangue/Hemocentro de São Paulo, São Paulo, Brazil.
  • Department of Hematology, Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), HCFMUSP, São Paulo, Brazil.
  • Laboratório de Medicina Laboratorial (LIM-03), HCFMUSP, São Paulo, Brazil.
  • Gastroenterology and Tropical Hepatology Laboratory (LIM/07), Institute of Tropical Medicine/University of São Paulo Medical School, São Paulo, Brazil.
  • Department of Gastroenterology, Hospital das Clínicas, School of Medicine, University of São Paulo, São Paulo, Brazil.
  • Molecular Virology, Department of Infectious Diseases, University Hospital Heidelberg, Heidelberg, Germany.

ORCID-Profile: Anna S Nishiya, Cecilia S Alencar, Michele Soares Gomes Gouvea, Alfredo Mendrone, Stephan Urban, Raymond F Schinazi

Zitieren

APA

Nishiya, A. S., Alencar, C. S., Gouvea, M. S. G., Ono, S. K., Salles, N. A., Mendrone, A., Gnouamozi, G. E., Nkongolo, S., Urban, S., Schinazi, R. F., & Bassit, L. (2026). Absence of Detectable Anti‐ HDV Antibodies Among HBsAg ‐Positive Blood Donors, HIV ‐Infected Individuals and Patients With Chronic Hepatitis B in Sao Paulo, Brazil: Evaluation Using a Rapid Lateral Flow Assay. Journal of Viral Hepatitis, 33(8). https://doi.org/10.1111/jvh.70217

Vancouver

Nishiya AS, Alencar CS, Gouvea MSG, Ono SK, Salles NA, Mendrone A, et al. Absence of Detectable Anti‐ HDV Antibodies Among HBsAg ‐Positive Blood Donors, HIV ‐Infected Individuals and Patients With Chronic Hepatitis B in Sao Paulo, Brazil: Evaluation Using a Rapid Lateral Flow Assay. Journal of Viral Hepatitis. 2026;33(8). doi:10.1111/jvh.70217

BibTeX
@article{Nishiya2026,
  author = {Nishiya, Anna S and Alencar, Cecilia S and Gouvea, Michele Soares Gomes and Ono, Suzane K and Salles, Nanci Alves and Mendrone, Alfredo and Gnouamozi, Gnimah Eva and Nkongolo, Shirin and Urban, Stephan and Schinazi, Raymond F and Bassit, Leda},
  title = {Absence of Detectable Anti‐ HDV Antibodies Among HBsAg ‐Positive Blood Donors, HIV ‐Infected Individuals and Patients With Chronic Hepatitis B in Sao Paulo, Brazil: Evaluation Using a Rapid Lateral Flow Assay},
  journal = {Journal of Viral Hepatitis},
  year = {2026},
  volume = {33},
  number = {8},
  doi = {10.1111/jvh.70217}
}
Kostenlos starten →